Goldman Sachs Group Inc Gossamer Bio, Inc. Transaction History

Goldman Sachs Group Inc

  • $613 Billion
  • Q4 2024

A detailed history of Goldman Sachs Group Inc transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 114,556 shares of GOSS stock, worth $160,378. This represents 0.0% of its overall portfolio holdings.

Number of Shares
114,556
Previous 730,754 84.32%
Holding current value
$160,378
Previous $723,000 85.75%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025
SELL
$0.66 - $1.07 $406,690 - $659,331
-616,198 Reduced 84.32%
114,556 $103,000
Q3 2024

Nov 14, 2024
SELL
$0.79 - $1.25 $1.1 Million - $1.73 Million
-1,386,960 Reduced 65.49%
730,754 $723,000
Q2 2024

Aug 13, 2024
SELL
$0.51 - $1.27 $293,888 - $731,838
-576,251 Reduced 21.39%
2,117,714 $1.91 Million
Q1 2024

May 15, 2024
SELL
$0.8 - $1.51 $25,828 - $48,751
-32,286 Reduced 1.18%
2,693,965 $3.18 Million
Q4 2023

Feb 13, 2024
BUY
$0.48 - $1.08 $509,639 - $1.15 Million
1,061,749 Added 63.79%
2,726,251 $2.48 Million
Q3 2023

May 14, 2024
SELL
$0.78 - $1.82 $828,164 - $1.93 Million
-1,061,749 Reduced 38.95%
1,664,502 $1.38 Million
Q3 2023

Nov 14, 2023
BUY
$0.78 - $1.82 $983,295 - $2.29 Million
1,260,635 Added 312.14%
1,664,502 $1.38 Million
Q2 2023

May 14, 2024
SELL
$0.98 - $1.53 $909,395 - $1.42 Million
-927,955 Reduced 69.68%
403,867 $484,000
Q2 2023

Aug 14, 2023
SELL
$0.98 - $1.53 $909,395 - $1.42 Million
-927,955 Reduced 69.68%
403,867 $484,000
Q1 2023

May 14, 2024
SELL
$0.96 - $2.92 $419,515 - $1.28 Million
-436,995 Reduced 24.71%
1,331,822 $1.68 Million
Q1 2023

May 11, 2023
SELL
$0.96 - $2.92 $419,515 - $1.28 Million
-436,995 Reduced 24.71%
1,331,822 $1.68 Million
Q4 2022

May 14, 2024
BUY
$1.74 - $12.87 $1.25 Million - $9.23 Million
717,305 Added 68.22%
1,768,817 $3.84 Million
Q4 2022

Feb 13, 2023
BUY
$1.74 - $12.87 $1.25 Million - $9.23 Million
717,305 Added 68.22%
1,768,817 $3.84 Million
Q3 2022

May 14, 2024
BUY
$7.21 - $14.88 $2.96 Million - $6.11 Million
410,923 Added 64.15%
1,051,512 $12.6 Million
Q3 2022

Nov 10, 2022
BUY
$7.21 - $14.88 $2.96 Million - $6.11 Million
410,923 Added 64.15%
1,051,512 $12.6 Million
Q2 2022

May 14, 2024
SELL
$5.97 - $9.97 $12.5 Million - $20.8 Million
-2,085,662 Reduced 76.5%
640,589 $5.36 Million
Q2 2022

Aug 15, 2022
BUY
$5.97 - $9.97 $1.1 Million - $1.84 Million
184,697 Added 40.51%
640,589 $5.36 Million
Q1 2022

May 16, 2022
BUY
$8.44 - $12.49 $1.79 Million - $2.65 Million
211,804 Added 86.77%
455,892 $3.96 Million
Q4 2021

Feb 14, 2022
SELL
$10.12 - $14.07 $3.32 Million - $4.61 Million
-327,829 Reduced 57.32%
244,088 $2.76 Million
Q3 2021

Nov 10, 2021
BUY
$7.25 - $13.23 $4.15 Million - $7.57 Million
571,917 New
571,917 $7.19 Million

Others Institutions Holding GOSS

# of Institutions
116
Shares Held
163M
Call Options Held
821K
Put Options Held
557K
View Full List

About Gossamer Bio, Inc.

GOSS Quotes by TradingView
  • Ticker GOSS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,954,000
  • Market Cap $132M
  • Description
  • Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...
More about GOSS
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email